QUEBEC CITY, Jan. 27 /CNW/ - Medicago Inc. (TSX-V : MDG) (the "Company"),
today announced that its abstract has been selected for a poster presentation
at the Infectious Diseases Society of America (IDSA) Seasonal and Pandemic
Influenza 2009 meeting, held in Washington, DC from February 2-3, 2009. Dr.
Sonia Trépanier will present highlights of the Company's development of
Influenza vaccines generated from plant-made Virus-Like Particles ("VLP") and
the potential of its proprietary manufacturing technology to address global
pandemic influenza supply challenges.
